Clinical trials query results

From Health Canada


New search



Medical condition:
MALIGNANT PLEURAL MESOTHELIOMA
Medical condition:
ADULT FEMALE,ADULT MALE
Drug name:
BAY 94-9343 (ANETUMAB RAVTANSINE) / VINORELBINE
Protocol title:
A RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED, PHASE II STUDY OF INTRAVENOUS ANETUMAB RAVTANSINE (BAY 94-9343) OR VINORELBINE IN PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT PLEURAL MESOTHELIOMA OVEREXPRESSING MESOTHELIN AND PROGRESSED ON FIRST LINE PLATINUM/ PEMETREXED-BASED CHEMOTHERAPY
Sponsor name:
BAYER INC
Date of no objection letter:
2015-12-04
Control number:
189220
Trial status:
CLOSED
Date study started:
2016-12-09
Date study completed:
2019-07-11
Date modified: